Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s stock price was down 8.4% during mid-day trading on Tuesday . The company traded as low as $0.19 and last traded at $0.19. Approximately 1,356,308 shares traded hands during trading, an increase of 71% from the average daily volume of 794,846 shares. The stock had previously closed at $0.21.
Azitra Trading Down 8.4%
The business has a 50-day moving average of $0.26 and a 200-day moving average of $0.31.
Institutional Trading of Azitra
A hedge fund recently raised its stake in Azitra stock. Virtu Financial LLC increased its holdings in shares of Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report) by 196.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,180 shares of the company’s stock after purchasing an additional 41,866 shares during the quarter. Virtu Financial LLC owned 0.83% of Azitra worth $27,000 at the end of the most recent reporting period. 11.16% of the stock is currently owned by hedge funds and other institutional investors.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
See Also
- Five stocks we like better than Azitra
- 3 Fintech Stocks With Good 2021 Prospects
- Should Investors Lock Arms With Buffett and Dive Into POOL Stock?
- What is a SEC Filing?
- Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2
- What Are Growth Stocks and Investing in Them
- Analysts Are Upgrading These 3 Massive AI Stocks After Earnings
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
